TYPE 2 diabetesConventionally, specialists become involved in the later stages of Type 2 diabetes mellitus, whereas evidence supports the role of time﹍imited specialist input at the start of treatment journey. The diagnosis of Type 2 diabetes should be seen as a key opportunity for ...
Diabetes is one of the most common chronic diseases that severely reduce a patient’s quality of life. Effective self-care and management are critical for maintaining blood glucose levels and preventing complications. This study evaluates the effectivene
Diabetes Professional Care is the UK's leading event for those involved in the prevention, treatment and management of diabetes and its related conditions, now incorporating Cardiovascular Professional Care.
2020 Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee J Am Coll Cardiol (2020) D.J. Magliano et al. Young-onset type 2 diabetes mellitus - impli...
Type 1 diabetes (T1D) is an autoimmune disease that can be diagnosed before its clinical stage of permanent hyperglycemia and insulin deficiency by screening for islet autoantibodies (aAbs). Clinical T1D is associated with an excess mortality, and there are two major arguments in favor of early...
The Adaptive Healthcare Pathway (AHP) concept developed and integrated in a technological platform for diabetes disease management, implements a shift from a healthcare organization-centred care to patient-centred care. The system was tested in a small-scale exploratory study. Results, focused on ...
2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol. 2020;76(9):1117-1145. doi:10.1016/j.jacc.2020.05.037PubMedGoogle...
Up to90% of prediabetesand type 2 diabetes can be avoided by making lifestyle changes. How mHealth solutions can support disease prevention and management For now, preventive health measures continue to be largely underutilized, but the ongoing advancement of mobile and connected technologies is ex...
Type 2 diabetes BMI change pathways Healthcare costs Weight change Economic burden 1. Introduction Obesity is reaching pandemic levels making it one of the biggest public health problems leading to severe health problems [1]. Being overweight is a major risk factor for the development of type 2 ...
Similar to DPP4 inhibitors, GLP-1 agonists are incretin mimetics that work by manipulating the incretin pathway to potentiate insulin secretion, slow gastric emptying, and reduce glucagon release. GLP-1 agonists are injectable agents used as second-line therapies to treat type 2 diabetes, although ...